Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis.
Oka
Yasunori
Y
Kanbayashi
Takashi
T
Mezaki
Takahiro
T
Iseki
Kazumi
K
Matsubayashi
Jun
J
Murakami
Gaku
G
Matsui
Masaru
M
Shimizu
Tetsuo
T
Shibasaki
Hiroshi
H
D000328:Adult; D002352:Carrier Proteins / Q000134:cerebrospinal fluid*; D006970:Disorders of Excessive Somnolence / Q000134:cerebrospinal fluid* / Q000209:etiology / Q000473:pathology*; D015536:Down-Regulation / Q000502:physiology; D005260:Female; D006801:Humans; D007031:Hypothalamus / Q000473:pathology* / Q000503:physiopathology*; D047908:Intracellular Signaling Peptides and Proteins; D008775:Methylprednisolone / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D009479:Neuropeptides / Q000134:cerebrospinal fluid* / Q000172:deficiency; D000068797:Orexins; D020923:REM Sleep Parasomnias / Q000134:cerebrospinal fluid / Q000209:etiology / Q000473:pathology; D016896:Treatment Outcome
D002352:Carrier Proteins; C000596229:HCRT protein, human; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins; D008775:Methylprednisolone